Gastrointestinal-related events, including nausea, vomiting, decreased appetite, and weight loss, were prevalent across both adult and geriatric populations
However, among GLP-1 dual-target drugs, tirzepatide, the first marketed peptide drug, currently has no plans for an oral version
and R.P.)
It carries an FDA black box warning for a risk of thyroid C-cell tumors, based on animal studies [5]
By making mindful choices, you can support muscle preservation, boost energy, and improve your overall well being
CrossRef Multicentre prospective trial of abbreviated MRI using gadoxetic acid versus CT for detection of late recurrent HCC (AMRICT): study protocol Hyo Jung Park, Dong Ho Lee, Won Chang, Hae Young Kim, Dong Hwan Kim, Won-Mook Choi, Sung Won Chung, Jonggi Choi, Danbi Lee, Ju Hyun Shim, Han Chu Lee, Young-Suk Lim, Seon-Ok Kim, Amit G Singal, So Yeon Kim BMJ Open .2026